Increased Expression of Beta-Defensin 1 in Chronic Obstructive Pulmonary Disease
Author Information
Author(s): Andresen Ellen, Günther Gunar, Bullwinkel Jörn, Lange Christoph, Heine Holger
Primary Institution: Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Borstel, Germany
Hypothesis
DEFB1 is differently regulated and expressed in human lungs during COPD progression.
Conclusion
DEFB1 mRNA expression is significantly increased in patients with COPD and correlates with decreased lung function.
Supporting Evidence
- DEFB1 mRNA expression was significantly increased in bronchopulmonary specimens of patients with COPD compared to healthy controls.
- A significant correlation was detected between DEFB1 and functional parameters such as FEV1.
- Upregulation of DEFB1 mRNA was paralleled by changes in HDAC1-3, HDAC5, and HDAC8 mRNA expression.
- Histone modifications were associated with the increased DEFB1 mRNA expression in COPD patients.
Takeaway
This study found that a protein called DEFB1 is made in larger amounts in the lungs of people with a lung disease called COPD, which is linked to how well they can breathe.
Methodology
Gene expression of DEFB1 was assessed in bronchial epithelium and BAL fluid cells of healthy controls and patients with COPD using bisulfite sequencing and ChIP analysis.
Participant Demographics
34 patients with COPD (stages 1-4) and 10 healthy controls.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website